ArticleCancer research and treatment2024

Clinical Validation of the Unparalleled Sensitivity of the Novel Allele-Discriminating Priming System Technology-Based EGFR Mutation Assay in Patients with Operable Non-Small Cell Lung Cancer.

Il-Hyun Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.